TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Jordyn Tarazi
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics announced granting non-qualified stock options to newly hired employees, with 23,600 shares to be vested over a four-year period under their 2024 Inducement Plan.

Insights
ALGS   neutral

The company is making a standard employee compensation move by granting stock options, which is a typical practice for attracting and retaining talent in the biotech industry